Association of Low Nodal Positivity Rate among Patients with ERBB2 -Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy

Alison U. Barron, Tanya L. Hoskin, Courtney N. Day, E. Shelley Hwang, Henry M. Kuerer, Judy C. Boughey

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'Association of Low Nodal Positivity Rate among Patients with ERBB2 -Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences